Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-047-7 | CAS number: 102-69-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Study period:
- January 1988
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented publication, which meets basic scientific principles
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- publication
- Title:
- Experimental study on the metabolism of triethylamine in man
- Author:
- Akesson, B., Skerfving S., Mattiasson, L.
- Year:
- 1 988
- Bibliographic source:
- British Journal of Industrial Medicine: 45,|262-268, (1988)
Materials and methods
- Objective of study:
- metabolism
- Principles of method if other than guideline:
- no data
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Triethylamine
- EC Number:
- 204-469-4
- EC Name:
- Triethylamine
- Cas Number:
- 121-44-8
- Molecular formula:
- C6H15N
- IUPAC Name:
- N,N-diethylethanamine
- Details on test material:
- - Name of test material (as cited in study report): Triethylamine
- Substance type: organic
- Stability under test conditions: stability of urine samples with respect to TEA and triethylamine-N-oxide (TEAO) was excellent; no loss of TEA or TEAO was found at storage at 25 °C with or without additions for three weeks and not in acidified samples stored at 4 °C for one year.
- Storage condition of test material: at 4 °C in polyethylene bottles for acidified 82 mL concentrated HCl per 100 mL) urine samples or at 4°C for acidified (0.5 mL 1 M HCl) 2mL plasma samples
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- human
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Five healthy male volunteers,
age 46-52 (mean 49)
body weight 78-84 (mean 82) kg,
height 1.075-1.84 (mean 1.81) m
Administration / exposure
- Route of administration:
- inhalation
- Vehicle:
- other: air
- Duration and frequency of treatment / exposure:
- 4 or 8 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
10; 20; 35 and 50 mg/m3
- No. of animals per sex per dose / concentration:
- 5 humans
- Control animals:
- not specified
- Positive control reference chemical:
- not applicable
- Details on study design:
- - Dose selection rationale: also higher doses as found in industrial workers (>20 mg/m3)
The total experience indicates that the time weighted average (TWA) exposure in the workroom should not exceed 10 mg/m3. - Details on dosing and sampling:
- METABOLITE CHARACTERISATION STUDIES
- Tissues and body fluids sampled: urine, venous blood, expiratory air
- Time and frequency of sampling: see below
- Method type(s) for identification: gas liquid chromatography
- Limits of detection and quantification: 0.01 mg/m3 for air samples (15 liter sample), 0 .1 µmol TEA/I urine and plasma
Urine was sampled at the start of exposure and then for periods of two hours during the exposure period, during four successive two hour periods after the end of exposure, and then during an additional seven hours, and at least during two additional four hour periods.
On four occasions, venous blood was sampled during exposure, as well as one and two to three hours after the end of exposure.
In one subject, at two different exposure concentrations, expiratory air was sampled during the final 10 minutes ofeach two hour exposure period and one and two hours after the end of exposure. Expired air was collected with a Douglas bag from all subjects while sitting in the chamber (reading) to determine the respiratory rate. - Statistics:
- no data
Results and discussion
- Preliminary studies:
- TEA may cause visual disturbances (Akesson, 1986 and 1985).
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Using the respiratory rate in combination with the air TEA concentrations, the mean amounts of inhaled TEA were calculated. In the 20 mg/m3 experiments the average was 929 µmol, in the 10 mg/m3 experiments 433 µmol. The corresponding mean amounts of U-TEA were 655 and 337 1smol during the exposure period and 23-32 hours after.
The concentrations of TEA in exhaled air are about 20% of those in inhaled air, with no trend during the exposure. This corresponds approximately to the difference between pulmonary ventilation and alveolar ventilation at rest. The exhaled amount corresponds to the fraction of the tidal volume occupied by the dead space. It is thus probable that the absorption of the TEA which reaches the alveolar region is complete. This is in agreement with the extreme water solubility of TEA. - Details on distribution in tissues:
- 24% of the exposure concentration was measured on the average in plasma and urine as a Triethylamine-N-Oxide.
The distribution was dependent upon the measured concentration in the urine, the half life amounted to 3.2 hours.
The plasma concentrations of TEA (P-TEA) increased in the four hour exposure sample on the four occasions studied (in three subjects). There was a further increase in the eight hour samples.
- Details on excretion:
- The plasma and urinary concentrations of TEA and TEAO decreased rapidly after the end of exposure
24% of the exposure concentration was measured on the average in plasma and urine as a Triethylamine-N-Oxide.
The distribution was dependent upon the measured concentration in the urine, the half life amounted to 3.2 hours.
The present data indicate that the major part of the absorbed TEA is excreted in the urine as such. If it is assumed that the absorption of the inhaled amount is 80% (vide supra) the median excretion in different experiments was 93%. The efficient excretion in urine is not surprising, considering the h gh water solubility of the compound.
During an eight hour exposure, the urinary concentration of TEA (U-TEA) was increased in the two hour period after onset of exposure, at exposure of 20 and 10 mg/m3. A continuous further increase followed and a steady state was not reached during the exposure as there was an increase between the 4-6 hour and the 6-8 hour samples. One subject showed an increase of U-TEA at both 20 and 10 mg/m3 0-2 hours after exposure. Another subject displayed a corresponding increase in the 20 mg/m3, but a decrease in his 10 mg/m3, experiment. In the other six experiments in three subjects there was a decrease. Later on, U-TEA decreased. During the 23-32 hours surveyed after the end of exposure, nobody reached the detection limit. The half lives of TEA excretion in urine after end of exposure at 10 mg/m3 averaged 3 1 (range 2 7-3-6) hours, and at 20 mg/m3, 3-4(2 5-45) hours. The fits to the exponential decay curves were good.
One hour after the end of exposure, Plasma TEA decreased in all experiments. The concentrations were still well above the dectection limit after 2-3 hours in all experiments.
The amounts of UTEAO were 219 and 103 µmol. The TEA and TEAO excreted in urine corresponds to an average of 97% (range 81-117) of the calculated inhaled amount of TEA.
In subject No 1 the exhalation of TEA was measured. The concentration before exposure was below the detection limit. Measurements were also made during the final 10 minutes in each two hour period of exposure. At an air TEA concentration of 20.1mg/m3, the level in exhaled air was 3.6-4.2 mg/m3 (18-21% of the concentration in inhaled air). One hour after end of exposure, the level was 0.2 mg/m3 and two hours after it was 0.1 mg/m3. At an air concentration of 9.9 mg/m3, the concentrations in exhaled air were 1.6 - 2.2 mg/m3 (18-20% of concentrations in inhaled air). After the end of exposure, the concentrations were 0.2 (1 h) and 0.1 (2 h) mg/m3, respectively. So only a minor excretion through exhalation.
Toxicokinetic parameters
- Toxicokinetic parameters:
- half-life 1st: mean 3.2 hours
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- Triethylamine-N-Oxide (TEAO)
Any other information on results incl. tables
VISUAL DISTURBANCES: The subject who was exposed to a TEA air level of 53 mg for four hours developed visual symptoms (blue haze), as did both subjects exposed to 35 mg/m3 for four hours and four of the five subjects exposed to 20 mg/m3 for eight hours. None had such symptoms at 10 mg/m3 for eight hours.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): low bioaccumulation potential based on study results
continously inhalation of TEA ends in a akkumulation in the human body - Executive summary:
Urinary determination is feasible for biological monitoring of TEA exposure.
It seems that determination of U-TEA, corrected for dilution of urine by use ofthe creatinine concentration, in urine sampled during the first two hours after the end of work is a useful index.
There was an excellent association between air levels of TEA and the urinary concentrations in samples obtained within two hours of the end of exposure. Thus the urinary level of TEA taken in this period is useful as a biological monitoring of exposure. An air concentration of 10 mg/m3 corresponds to an average urinary concentration of about 40 mmol/mol creatinine (at sedentary work).
Considering the extreme water solubility of the compound, it is probable that the absorption is proportional to ventilation. At moderately heavy work (ventilation 10 cm3/8h), an Air-TEA of 40 mg/ m3 would then correspond to an U-TEA of 320 mmol/ mol creatinine. Data on visual disturbances presented here and earlier,23 however, indicate that 40 mg/m3 is too high a TLV; 10 mg/m3 would be more reasonable. This would correspond to an average U-TEA of about 40 mmol/mol creatinine in a resting worker and 80 mmol/mol creatinine in moderately heavy industrial work.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)